NCT06664541View on ClinicalTrials.gov

Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy

Enrolling by invitationOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

December 1, 2026

Conditions

Transfusion Dependent Beta ThalassemiaSickle Cell Disease

Trial Locations (1)

20007

Georgetown University Medical Center, Washington D.C.

All Listed Sponsors

lead

Georgetown University

OTHER